Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
The purpose of this study is to 1) examine barriers and facilitators to implementation of MI and MORE for polysubstance use and evaluate strategies for optimizing training, fidelity, and clinic uptake, and 2) evaluate patient outcomes related to the effectiveness of MORE decreasing opioid, tobacco, and other drug use.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
420 participants in 4 patient groups
Loading...
Central trial contact
Nina Cooperman, PsyD; Eric Garland, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal